About Celestys Pharmaceuticals Private Limited
Data last updated:
Celestys Pharmaceuticals Private Limited was a private limited company based in Ahmedabad, Gujarat, India, operated as a subsidiary of Abhaya Investments Limited. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 February 2015.
The company was registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24233GJ2015PTC082278. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹15 Cr and a paid-up capital of ₹6.5 Cr. It was led by directors including Anil Kumar Sharma and Pravin Sahadev Thombare.
Its last annual general meeting (AGM) was held on 29 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office was at A – 44 Orchid Park Near Anjani Tower Ramdevnagar Satellite, Ahmedabad, Gujarat, India – 380015.
As per the financials filed for FY 2018, the company reported a revenue of ₹2.52 Lakh, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹58,129 (net margin 23.1%) and EBITDA of ₹90,099 (EBITDA margin 35.8%).
The last known website on record is celestyspharma.com.
Company details
Contact details
Celestys Pharmaceuticals Private Limited's registered office is in Ahmedabad, Gujarat. Its website is celestyspharma.com. Its e-mail address is in the company report.
- Email
- Website
- Registered AddressA – 44 Orchid Park Near Anjani Tower Ramdevnagar Satellite, Ahmedabad, Gujarat, India – 380015
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Celestys Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Celestys Pharmaceuticals Private Limited
FY 2018 filings availableCelestys Pharmaceuticals Private Limited reported revenue of ₹2.52 Lakh (up 10% YoY) for FY 2018.
Compounded Annual Growth Rate (CAGR)
Revenue rose 10% in the latest year. EBITDA rose 121% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹90,099 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹58,129 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 35.8% | |||
| Net Profit Margin | 23.1% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Celestys Pharmaceuticals Private Limited, buy the company report.
Board of directors of Celestys Pharmaceuticals Private Limited
Celestys Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anil Kumar Sharma | Director | 16 Feb 2015 | 11 Years 8 Months | As last reported |
| Shobhan Mandal Also directs: JSM Innovations LLP | Additional Director | 30 Jan 2017 | 9 Years 9 Months | As last reported |
| Pravin Sahadev Thombare Also directs: Celestis Pharmaceuticals Private Limited | Director | 16 Feb 2015 | 11 Years 8 Months | As last reported |
Peer comparison
Celestys Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Hands Bio-Tech Private Limited | ₹2.54 Lakh (FY 2024) | 150.0% | Kolkata, West Bengal, India | |||
| Macarty Pharmaceuticals Private Limited | ₹2.54 Lakh (FY 2024) | -46.0% | Lucknow, Uttar Pradesh, India | |||
| Aspire Pharmaceuticals Private Limited | ₹2.53 Lakh (FY 2025) | 724.0% | Raipur, Chhattisgarh, India | |||
| Lotuslife Pharmaceuticals Private Limited | ₹2.53 Lakh (FY 2025) | 16.0% | Delhi, India | |||
| Special Life Pharmaceuticals Private Limited | ₹2.53 Lakh (FY 2024) | -15.0% | Motihari, Bihar, India | |||
| Celestys Pharmaceuticals Private Limitedthis company | ₹2.52 Lakh (FY 2018) | ₹58,129 | 23.1% | 10.0% | Ahmedabad, Gujarat, India | |
| Space Pharmaceuticals Private Limited | ₹2.51 Lakh (FY 2024) | -29.0% | New Delhi, Delhi, India | |||
| Argen Pharmaceuticals Private Limited | ₹2.51 Lakh (FY 2025) | -91.0% | Delhi, India | |||
| Trenz Drugs Private Limited | ₹2.51 Lakh (FY 2024) | 5.0% | New Delhi, Delhi, India | |||
| Amorezen Pharmaceuticals Industries Private Limited | ₹2.51 Lakh (FY 2023) | -44.0% | Nagpur, Maharashtra, India | |||
| Genes4 Life Private Limited | ₹2.51 Lakh (FY 2025) | -92.0% | Bengaluru, Karnataka, India |
To see the full peer comparison of Celestys Pharmaceuticals Private Limited, buy the company report.
Auditor
Celestys Pharmaceuticals Private Limited is audited by KANTILAL PATEL & CO for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KANTILAL PATEL & CO | FY 2017 | 104744W |
Shareholding
The shareholding of Celestys Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Celestys Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Celestys Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Celestys Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Celestys Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Celestys Pharmaceuticals Private Limited, buy the company report.
Recent activity
Celestys Pharmaceuticals Private Limited has 4 board changes on record since 2015: 3 appointments and 1 cessation. The latest: Jayanta Kumar Mandal ceased to be Director on 15 Feb 2017.
Frequently asked questions
Celestys Pharmaceuticals has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Celestys Pharmaceuticals was a private limited company based in Ahmedabad, Gujarat, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 16 February 2015 and is registered under CIN U24233GJ2015PTC082278. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Celestys Pharmaceuticals was incorporated on 16 February 2015. It is registered with the Registrar of Companies, Ahmedabad.
Celestys Pharmaceuticals had 3 directors:
- Anil Kumar Sharma - Director
- Shobhan Mandal - Additional Director
- Pravin Sahadev Thombare - Director
The CIN (Corporate Identification Number) of Celestys Pharmaceuticals is U24233GJ2015PTC082278. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Celestys Pharmaceuticals is at A – 44 Orchid Park Near Anjani Tower Ramdevnagar Satellite, Ahmedabad, Gujarat, India – 380015.
Celestys Pharmaceuticals can be reached through the website celestyspharma.com. Its registered office is in Ahmedabad, Gujarat, India.
The latest financial statements of Celestys Pharmaceuticals on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 29 September 2018. Year-wise statements from 2015 are in the company report.
No. Celestys Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
Celestys Pharmaceuticals operated in the pharma industry, in the drug formulation and development segment.
The peers of Celestys Pharmaceuticals by revenue are Hands Bio-Tech Private Limited, Macarty Pharmaceuticals Private Limited, Aspire Pharmaceuticals Private Limited, Lotuslife Pharmaceuticals Private Limited, Special Life Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
